{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:05:42Z","timestamp":1773237942398,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ege University Research Projects","award":["12-TIP-017"],"award-info":[{"award-number":["12-TIP-017"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.gene.2017.09.036","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T03:18:09Z","timestamp":1505963889000},"page":"173-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia"],"prefix":"10.1016","volume":"637","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6797-7655","authenticated-orcid":false,"given":"Cagla","family":"Kayabasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tugce Balci","family":"Okcanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Besra Ozmen","family":"Yelken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aycan","family":"Asik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunde Yilmaz","family":"Susluer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigir Biray","family":"Avci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guray","family":"Saydam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6593-3237","authenticated-orcid":false,"given":"Cumhur","family":"Gunduz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2017.09.036_bb0005","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/15384047.2016.1235657","article-title":"MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition","volume":"17","author":"Afgar","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.gene.2017.09.036_bb0010","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1158\/1541-7786.MCR-08-0167","article-title":"Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth","volume":"6","author":"Agirre","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.gene.2017.09.036_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.gene.2017.09.036_bb0020","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI35660","article-title":"Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells","volume":"119","author":"Bellodi","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 1","key":"10.1016\/j.gene.2017.09.036_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/10428194.2010.546913","article-title":"Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors","volume":"52","author":"Calabretta","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.gene.2017.09.036_bb0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00432-015-2016-0","article-title":"MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer","volume":"142","author":"Chen","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.gene.2017.09.036_bb0035","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/nar\/gki200","article-title":"Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis","volume":"33","author":"Cheng","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2017.09.036_bb0040","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.gene.2017.09.036_bb0045","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2017.09.036_bb0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1083\/jcb.33.2.437","article-title":"Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes","volume":"33","author":"Deter","year":"1967","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.gene.2017.09.036_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI9083","article-title":"Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia","volume":"105","author":"Druker","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2017.09.036_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs - microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.gene.2017.09.036_bb0065","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/bcr3464","article-title":"MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer","volume":"15","author":"Guo","year":"2013","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.gene.2017.09.036_bb0070","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.0400067101","article-title":"A distinct \"side population\" of cells with high drug efflux capacity in human tumor cells","volume":"101","author":"Hirschmann-Jax","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2017.09.036_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-016-0493-7","article-title":"miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-kappaB signaling in gastric carcinogenesis","volume":"15","author":"Huang","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2017.09.036_bb0080","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4149\/neo_2017_306","article-title":"MicroRNA-1285 inhibits malignant biological behaviors of human pancreatic cancer cells by negative regulation of YAP1","volume":"64","author":"Huang","year":"2017","journal-title":"Neoplasma"},{"key":"10.1016\/j.gene.2017.09.036_bb0085","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","article-title":"MicroRNAs in cancer: small molecules with a huge impact","volume":"27","author":"Iorio","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gene.2017.09.036_bb0090","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4149\/neo_2015_115","article-title":"microRNA expression profiling as supportive diagnostic and therapy prediction tool in chronic myeloid leukemia","volume":"62","author":"Jurkovicova","year":"2015","journal-title":"Neoplasma"},{"key":"10.1016\/j.gene.2017.09.036_bb0095","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0301-472X(03)00069-9","article-title":"Mechanisms of Bcr-Abl-mediated NF-kappaB\/Rel activation","volume":"31","author":"Kirchner","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.gene.2017.09.036_bb0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.biopha.2017.01.137","article-title":"MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1","volume":"89","author":"Lei","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.gene.2017.09.036_bb0105","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1007\/s13277-015-4603-8","article-title":"miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R","volume":"37","author":"Li","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.gene.2017.09.036_bb0110","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbrc.2012.07.098","article-title":"Myc induced miR-144\/451 contributes to the acquired imatinib resistance in chronic myelogenous leukemia cell K562","volume":"425","author":"Liu","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2017.09.036_bb0115","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.3892\/or.2016.4749","article-title":"Tumor-suppressing roles of miR-214 and miR-218 in breast cancer","volume":"35","author":"Liu","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.gene.2017.09.036_bb0120","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3892\/or.2017.5431","article-title":"miR-922 regulates CYLD expression and promotes the cell proliferation of human hepatocellular carcinoma","volume":"37","author":"Liu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.gene.2017.09.036_bb0125","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.leukres.2011.03.029","article-title":"MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?","volume":"35","author":"Lopotova","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.gene.2017.09.036_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gene.2017.01.004","article-title":"Long noncoding RNA HULC promotes cell proliferation by regulating PI3K\/AKT signaling pathway in chronic myeloid leukemia","volume":"607","author":"Lu","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.gene.2017.09.036_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-10-41","article-title":"Expression patterns of microRNAs associated with CML phases and their disease related targets","volume":"10","author":"Machova Polakova","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2017.09.036_bb0140","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2239","article-title":"Self-eating and self-killing: crosstalk between autophagy and apoptosis","volume":"8","author":"Maiuri","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.gene.2017.09.036_bb0145","doi-asserted-by":"crossref","first-page":"37321","DOI":"10.18632\/oncotarget.16310","article-title":"Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancer","volume":"8","author":"Meng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2017.09.036_bb0150","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood-2007-03-066936","article-title":"Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia","volume":"110","author":"O'Hare","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.gene.2017.09.036_bb0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","article-title":"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance","volume":"16","author":"O'Hare","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2017.09.036_bb0160","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/ATVBAHA.116.308916","article-title":"microRNA-33 regulates macrophage autophagy in atherosclerosis","volume":"37","author":"Ouimet","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2017.09.036_bb0165","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Quintas-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.gene.2017.09.036_bb0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.leukres.2005.09.001","article-title":"Hematopoietic-specific microRNA expression in human cells","volume":"30","author":"Ramkissoon","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.gene.2017.09.036_bb0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-8-69","article-title":"MicroRNA expression profiling in Imatinib-resistant chronic myeloid leukemia patients without clinically significant ABL1-mutations","volume":"8","author":"San Jose-Eneriz","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2017.09.036_bb0180","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2017.09.036_bb0185","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.molonc.2015.01.008","article-title":"MicroRNA-30c-2-3p negatively regulates NF-kappaB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer","volume":"9","author":"Shukla","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.gene.2017.09.036_bb0190","first-page":"433","article-title":"Imatinib-resistant chronic myeloid leukemia (CML): current concepts on pathogenesis and new emerging pharmacologic approaches","volume":"1","author":"Valent","year":"2007","journal-title":"Biologics"},{"key":"10.1016\/j.gene.2017.09.036_bb0195","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/1471-2164-11-288","article-title":"Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood","volume":"11","author":"Vaz","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.gene.2017.09.036_bb0200","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1182\/blood-2006-09-045104","article-title":"Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells","volume":"109","author":"Venturini","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.gene.2017.09.036_bb0205","article-title":"Decreased expression of miR-874 and its tumor suppressive function in human colorectal cancer","volume":"15","author":"Wang","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.gene.2017.09.036_bb0210","doi-asserted-by":"crossref","first-page":"29914","DOI":"10.18632\/oncotarget.15530","article-title":"MiR-766 induces p53 accumulation and G2\/M arrest by directly targeting MDM4","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2017.09.036_bb0215","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.12659\/MSM.898121","article-title":"MicroRNA-340 inhibits tumor cell proliferation and induces apoptosis in endometrial carcinoma cell line RL 95-2","volume":"22","author":"Xie","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.gene.2017.09.036_bb0220","doi-asserted-by":"crossref","first-page":"22003","DOI":"10.18632\/oncotarget.15781","article-title":"MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2017.09.036_bb0225","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1177\/0300060513505266","article-title":"Effect of miR-29b-1* and miR-29c knockdown on cell growth of the bladder cancer cell line T24","volume":"41","author":"Xu","year":"2013","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.gene.2017.09.036_bb0230","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10495-012-0710-9","article-title":"miR-1228 prevents cellular apoptosis through targeting of MOAP1 protein","volume":"17","author":"Yan","year":"2012","journal-title":"Apoptosis"},{"key":"10.1016\/j.gene.2017.09.036_bb0235","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1038\/onc.2011.523","article-title":"MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-kappaB-inducing kinase (NIK)","volume":"31","author":"Zhang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2017.09.036_bb0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-4598-11-56","article-title":"The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia","volume":"11","author":"Zhang","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2017.09.036_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2017.02.121","article-title":"MicroRNA-520e suppresses non-small-cell lung cancer cell growth by targeting Zbtb7a-mediated Wnt signaling pathway","volume":"486","author":"Zhijun","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2017.09.036_bb0250","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopha.2016.07.037","article-title":"miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6","volume":"83","author":"Zhu","year":"2016","journal-title":"Biomed Pharmacother"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811191730759X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811191730759X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T01:32:35Z","timestamp":1602984755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037811191730759X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":50,"alternative-id":["S037811191730759X"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2017.09.036","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effect of imatinib and ponatinib on autophagy and miRNome in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2017.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}